This webinar will feature an academic case study on NaV1.9 as a drug target by Professor David Bulmer (University of Cambridge). The webinar will also include a presentation by Metrion CSO, Dr. Eddy Stevens with an overview of Metrion’s newly developed NaV1.9 screening assays.